Key result
Desmoplakin cardiomyopathy reveals distinct myocardial immune cell infiltration patterns in explanted hearts.
Why the study?
The cellular composition of inflammatory infiltrates in genetically defined desmoplakin cardiomyopathy remains poorly characterized despite evidence of immune activation in disease pathogenesis.
Observational
This study aims to define the specific cellular composition of inflammatory infiltrates in explanted hearts with desmoplakin cardiomyopathy, potentially clarifying the role of immune activation in its pathogenesis.
Answers are grounded in this paper and cite their sources.
May support immunomodulatory strategies in DSP cardiomyopathy; leaves open whether this alters progression or arrhythmias.
Desmoplakin (DSP) cardiomyopathy is characterized by recurrent myocarditis-like episodes, troponin release, and patchy late gadolinium enhancement on cardiac magnetic resonance imaging, suggesting that immune activation may be a central feature of disease pathogenesis rather than a secondary phenomenon.1 Pathogenic DSP variants disrupt desmosomal integrity, increasing susceptibility to cardiomyocyte injury.2 Histopathological studies of arrhythmogenic cardiomyopathy (ACM) have frequently demonstrated inflammatory infiltrates,3,4 but their cellular composition remains poorly characterized, particularly in genetically defined DSP cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Ezzeddine et al. (2026) conducted an observational in Desmoplakin (DSP) cardiomyopathy. Pathogenic DSP variants was evaluated. The study aims to characterize the cellular composition of myocardial immune cell infiltrates in explanted hearts from patients with genetically defined desmoplakin cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: